Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FD4VT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,780
Award facts
- Contract value 100% obligated
- $19,779.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.78K by the Defense Logistics Agency (DLA) on June 18, 2025. The contract calls for the delivery of Entyvio 300 mg vials, a biologic medication used to treat inflammatory bowel diseases, with an ultimate completion date of July 11, 2025. This award was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499.999 billion through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. No set-aside designation was applied to this particular delivery order.
The contract represents continued utilization of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. As an authorized distributor under the DLA's SPE2DB program, the company regularly fulfills delivery orders for specialized medications and biologics to Department of Defense healthcare sites. The firm fixed-price structure ensures cost certainty for this specific pharmaceutical delivery, with performance expected to conclude by mid-July 2025 at the designated place of performance in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DB25FD4VT?
SPE2DB25FD4VT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FD4VT worth?
The government has obligated $19,780 on SPE2DB25FD4VT.
Is contract SPE2DB25FD4VT an order under another contract?
Yes. SPE2DB25FD4VT is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4VT competed?
The extent of competition for SPE2DB25FD4VT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award